共 50 条
- [1] Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trialLANCET, 2018, 391 (10121): : 659 - 667Wang, MichaelRule, SimonZinzani, Pier LuigiGoy, AndreCasasnovas, OlivierSmith, Stephen D.Damaj, GandhiDoorduijn, JeanetteLamy, ThierryMorschhauser, FranckPanizo, CarlosShah, BijalDavies, AndrewEek, RichardDupuis, JehanJacobsen, EricKater, Arnon P.Le Gouill, StevenOberic, LucieRobak, TadueszCovey, ToddDua, RichaHamdy, AhmedHuang, XinIzumi, RaquelPatel, PritiRothbaum, WayneSlatter, J. GregJurczak, Wojciech
- [3] Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Long-Term Efficacy and Safety Results from a Phase 2 StudyBLOOD, 2020, 136Wang, MichaelRule, SimonZinzani, Pier LuigiGoy, Andre H.Casasnovas, Rene-OlivierSmith, Stephen D.Damaj, Gandhi LaurentDoorduijn, Jeanette K.Lamy, ThierryMorschhauser, FranckPanizo, CarlosShah, BijalDavies, AndrewEek, RichardDupuis, JehanJacobsen, EricKater, Arnon P.Le Gouill, StevenOberic, LucieRobak, TadeuszJain, PreeteshBrock, GrahamPatel, PritiTao, LinDlugosz-Danecka, Monika
- [4] Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell LymphomaBLOOD, 2023, 142Kim, Austin I.Armand, PhilippeRedd, Robert A.Forsyth, MeganBranch, PaulPazienza, SamanthaBrennan, LisaPatterson, VictoriaWaisgerber, Susan M.Merryman, Reid W.Fisher, David C.Ryan, Christine E.Ahn, Inhye E.Crombie, Jennifer L.Odejide, Oreofe O.LaCasce, AnnJacobson, Caron A.Jacobsen, EricParry, Erin M.Davids, Matthew S.Brown, Jennifer R.Freedman, Arnold S.Riedell, Peter A.Murakami, Mark Alan
- [5] Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphomaLEUKEMIA & LYMPHOMA, 2024, 65 (05) : 647 - 652Song, YuqinLi, JianyongZhou, KeshuKe, XiaoyanCai, ZhenZhang, HuilaiYao, TingtingXia, ZhenWang, YiqiuLai, PeiqiongLiu, XiaofengZhu, Jun
- [6] Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell LymphomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S316 - S316Wang, MichaelRule, SimonZinzani, Pier LuigiGoy, AndreCasasnovas, OliverSmith, StephenDamaj, GandhiDoorduijn, Jeanette K.Lamy, ThierryMorschhauser, FranckPanizo, CarlosShah, BijalDavies, AndrewEek, RichardDupuis, JehanJacobsen, EricKater, Arnon P.Le Gouill, StevenOberic, LucieRobak, TadeuszDua, RichaFrigault, Melanie M.Izumi, RaquelNguyen, DorothyPatel, PritiYin, MingJurczak, Wojciech
- [7] Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II StudyBLOOD, 2019, 134Song, YuqinSong, YongpingLiu, LihongZhang, MingzhiLi, ZhimingJi, ChunyanXu, WeiLiu, TingXu, BingWang, XinGao, SujunZhang, HuilaiHu, YuLi, YanCheng, YingYang, HaiyanCao, JunningZhu, ZunminHu, JiandaZhang, WeiJing, HongmeiDing, KaiyangLu, ZhengguangZhang, BinZhao, RenbinXu, ZhixinZhu, Jun
- [8] Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell LymphomaBLOOD, 2018, 132Wang, MichaelRule, SimonZinzani, Pier LuigiGoy, AndreCasasnovas, OlivierSmith, Stephen D.Damaj, GandhiDoorduijn, Jeanette K.Lamy, ThierryMorschhauser, FranckPanizo, CarlosShah, Bijal D.Davies, AndrewEek, RichardDupuis, JehanJacobsen, EricKater, Arnon P.Gouill, Steven L. E.Oberic, LucieRobak, TadeuszDua, RichaFrigault, Melanie M.Izumi, RaquelNguyen, DorothyPatel, PritiYin, MingJurczak, Wojciech
- [9] Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphomaCANCER SCIENCE, 2016, 107 (12) : 1785 - 1790Maruyama, DaiNagai, HirokazuFukuhara, NorikoKitano, ToshiyukiIshikawa, TakayukiShibayama, HirohikoChoi, IlseungHatake, KiyohikoUchida, ToshikiNishikori, MomokoKinoshita, TomohiroMatsuno, YoshihiroNishikawa, TomoakiTakahara, SatokoTobinai, Kensei
- [10] A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaBRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (01) : 76 - 85Strati, PaoloColeman, MortonChampion, RebeccaMa, ShuoPatti, CaterinaLevy, Moshe Y.Lossos, Izidore S.Geethakumari, Praveen RamakrishnanLam, SelayCalvo, RoserHiggins, KaraBudde, Lihua E.